GNI Ltd. (Exited)
Drug discovery based on gene network analysis
GNI develops therapeutic pharmaceutical products, using Genome analysis. The Company targets disease indigenous to Asian countries. GNI controls the whole process of drug discovery by conducting clinical trials, research and development, and marketing. The company owns global subsidiaries in China and the US.